Botanical species · safety record

Cochlearia officinalis

The EFSA Compendium of Botanicals holds 8 constituent measurements for Cochlearia officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cochlearia officinalis L.

8Constituent measurements

0Safety records

4Cited sources

2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Cochlearia officinalis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Flowering herb

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Glucocochlearin	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Glucoputranjivin	Aerial part of plants	Solvent extraction	—	HPLC-DAD	Resolve DOI
Calystegine a5	Unspecified	Solvent extraction	1600 Microgram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Calystegine b2	Unspecified	Solvent extraction	34 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Calystegine b3	Unspecified	Solvent extraction	85 Microgram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Glucobrassicin	Live plants	—	≥ 22 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Glucobrassicin	Live plants	—	≤ 172 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Tropine	Unspecified	Solvent extraction	6.3 Microgram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Dauvergne, Xavier., Cerantola, Stephane., Salaun, Stephanie., Magne, Christian., Kervarec, Nelly., Bessieres, Marie-Anne., Deslandes, Eric. General occurrence of the glucosinolate glucocochlearin within the Cochlearia genus. CARBOHYDRATE RESEARCH, 2006, vol. 341, no. 12, p. 2166-2169. DOI
Strusovskaya, O. G. Determination of alkaloids from Cochlearia officinalis. Khimiya Rastitel'nogo Syr'ya, 2012, p. 125-131.
Dauvergne, X., Cerantola, S., Magne, C., Deslandes, E., Bessieres, MA. Evidence for the common occurrence of the glucosinolate glucoputranjivin in the genus Cochlearia. BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2006, vol. 34, no. 7, p. 596-598. DOI
Baeuerle, R., Wagner, H., Schraudolf, H. Distribution of 4-methoxy-3-indolylmethylglucosinolate (4-methoxyglucobrassicin) in Brassicaceae. Experientia, 1986.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature